Salud financiera de hoja de balance de Formosa Laboratories

Salud financiera controles de criterios 6/6

Formosa Laboratories tiene un patrimonio de accionistas total de NT$8.2B y una deuda total de NT$4.0B, lo que sitúa su ratio deuda-patrimonio en 49%. Sus activos y pasivos totales son NT$13.6B y NT$5.4B respectivamente. El BAIT de Formosa Laboratories es de NT$675.0M, por lo que su ratio de cobertura de intereses es de 61.2. Tiene efectivo e inversiones a corto plazo que ascienden a NT$2.5B.

Información clave

49.0%

Ratio deuda-patrimonio

NT$4.02b

Deuda

Ratio de cobertura de intereses	61.2x
Efectivo	NT$2.51b
Patrimonio	NT$8.21b
Total pasivo	NT$5.43b
Activos totales	NT$13.64b

Actualizaciones recientes sobre salud financiera

Here's Why Formosa Laboratories (TPE:4746) Has A Meaningful Debt Burden

Apr 19

Formosa Laboratories (TPE:4746) Is Making Moderate Use Of Debt

Jan 11

Recent updates

Benign Growth For Formosa Laboratories, Inc. (TWSE:4746) Underpins Its Share Price

Apr 19

Here's Why Formosa Laboratories (TPE:4746) Has A Meaningful Debt Burden

Apr 19

Does Formosa Laboratories, Inc.'s (TPE:4746) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?

Mar 16

What Type Of Returns Would Formosa Laboratories'(TPE:4746) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Feb 08

Formosa Laboratories (TPE:4746) Is Making Moderate Use Of Debt

Jan 11

Formosa Laboratories's (TPE:4746) Earnings Are Growing But Is There More To The Story?

Dec 13

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$5.2B) de 4746 superan a sus pasivos a corto plazo (NT$3.2B).

Pasivo a largo plazo: Los activos a corto plazo de 4746 (NT$5.2B) superan a sus pasivos a largo plazo (NT$2.2B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (18.4%) de 4746 se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de 4746 ha pasado de 70.3% a 49% en los últimos 5 años.

Cobertura de la deuda: La deuda de 4746 está bien cubierta por el flujo de caja operativo (20.6%).

Cobertura de intereses: Los pagos de intereses de la deuda de 4746 están bien cubiertos por el BAIT (61.2x cobertura).

Salud financiera de hoja de balance de Formosa Laboratories

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Here's Why Formosa Laboratories (TPE:4746) Has A Meaningful Debt Burden

Formosa Laboratories (TPE:4746) Is Making Moderate Use Of Debt

Recent updates

Formosa Laboratories, Inc. to Report Q1, 2024 Results on May 09, 2024

Formosa Laboratories, Inc. to Report Q1, 2024 Results on May 09, 2024

Benign Growth For Formosa Laboratories, Inc. (TWSE:4746) Underpins Its Share Price

Formosa Laboratories, Inc., Annual General Meeting, Jun 25, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Investor sentiment improves as stock rises 15%

New minor risk - Earnings quality

Investor sentiment improves as stock rises 18%

Formosa Laboratories, Inc. Announces Change of Members of the Sustainable Development Committee

Upcoming dividend of NT$1.00 per share at 1.2% yield

Second quarter 2023 earnings released: EPS: NT$0.69 (vs NT$0.071 loss in 2Q 2022)

Formosa Laboratories, Inc. Appoints Lin Chien-Fei as Chief Information Security Officer

Formosa Laboratories, Inc. Announces Cash Dividend, Payable on September 22, 2023

Formosa Laboratories, Inc. Approves Independent Directors Elections

Investor sentiment improves as stock rises 15%

Full year 2022 earnings released: EPS: NT$3.40 (vs NT$10.92 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$4.09 (vs NT$3.20 loss in 3Q 2021)

Second quarter 2022 earnings released: NT$0.07 loss per share (vs NT$6.86 profit in 2Q 2021)

Upcoming dividend of NT$2.00 per share

First quarter 2022 earnings released: NT$3.33 loss per share (vs NT$9.84 profit in 1Q 2021)

Price target decreased to NT$55.00

Less than half of directors are independent

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: NT$3.20 loss per share (vs NT$0.93 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS NT$6.86 (vs NT$4.99 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS NT$9.84 (vs NT$1.03 loss in 1Q 2020)

Here's Why Formosa Laboratories (TPE:4746) Has A Meaningful Debt Burden

Investor sentiment improved over the past week

Does Formosa Laboratories, Inc.'s (TPE:4746) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?

Full year 2020 earnings released: EPS NT$3.78 (vs NT$0.12 in FY 2019)

Investor sentiment improved over the past week

New 90-day high: NT$52.80

What Type Of Returns Would Formosa Laboratories'(TPE:4746) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Formosa Laboratories (TPE:4746) Is Making Moderate Use Of Debt

Formosa Laboratories's (TPE:4746) Earnings Are Growing But Is There More To The Story?

New 90-day low: NT$47.80

Third quarter 2020 earnings released: EPS NT$0.93

New 90-day low: NT$48.40

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera